[Federal Register Volume 81, Number 155 (Thursday, August 11, 2016)]
[Notices]
[Pages 53162-53163]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19035]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical CBRN Defense Consortium (Formerly
National Chemical Biological Defense Consortium)
Notice is hereby given that, on June 23, 2016, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), National Chemical Biological
Defense Consortium (``NCBDC'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. National Chemical & Biological Defense Consortium
(``NCBDC'') has changed its name to Medical CBRN Defense Consortium
(``MCDC''). Specifically, AdjuvanceTechnologies, Inc., New York, NY;
AEQUOR, Inc., Oceanside, CA; AktiVax, Inc., Boulder, CO; Alchem
Laboratories Corp., Alachua, FL; Artificial Cell Technologies, Inc.,
New Haven, CT; Bach Pharma, Inc., North Andover, MA; Battelle Memorial
Institute, Columbus, OH; Bryllan LLC, Brighton, MI; Creare LLC,
Hanover, NH; CUBRC, Inc., Buffalo, NY; Data Sciences International,
Inc., St. Paul, MN; First Line Technology, LLC, Chantilly, VA; Ginkgo
Bioworks, Boston, MA; Harris Corporation, Herndon, VA; IIT Research
Institute, Chicago, IL; Integrated Biotherapeutics, Inc., Gaithersburg,
MD; InvivoSciences, Inc., Madison, WI; Joint Research and Development,
Inc., Stafford, VA; Mapp BioPharmaceuticals, San Diego, CA; MaxCyte,
Incorporated, Gaithersburg, MD; MRIGlobal, Kansas City, MO;
Nanotherapeutics, Inc., Alachua, FL; Philips Healthcare, Andover, MA;
Profectus BioSciences, Inc., Baltimore, MD; ProModel Corporation,
Allentown, PA; QuickSilver Analytics, Inc., Belcamp, MD; SciTech
Services, Inc., Havre de Grace, MD; SENTEL Corporation, Alexandria, VA;
Shield Analysis Technology, LLC, Manassas, VA; Southwest Research
Institute, San Antonio, TX; SRI International, Menlo Park, CA; Tech62,
Fairfax, VA; Triton Systems, Inc., Chelmsford, MA; University of
Pittsburgh, Pittsburgh, PA; University of Tennessee, Knoxville,
Knoxville, TN; and Verndari Inc., Napa,
[[Page 53163]]
CA, have been added as parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MCDC intends to file additional
written notifications disclosing all changes in membership.
On November 13, 2015, NCBDC filed its original notification
pursuant to Section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to Section 6(b) of
the Act on January 6, 2016 (81 FR 513).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2016-19035 Filed 8-10-16; 8:45 am]
BILLING CODE 4410-11-P